Wall Street analysts forecast that Zoetis (ZTS) will report quarterly earnings of $1.35 per share in its upcoming release, pointing to a year-over-year increase of 3.1%. It is anticipated that revenues will amount to $2.14 billion, exhibiting an increase of 7% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 0.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their i ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Let's take a look at what these Wall Street heavyweights have to say about Zoetis (ZTS) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Zoetis currently has an average brok ...

In the latest trading session, Zoetis (ZTS) closed at $145.54, marking a -0.66% move from the previous day. This change lagged the S&P 500's daily gain of 0.87%. At the same time, the Dow added 0.67%, and the tech-heavy Nasdaq gained 1.11%.Shares of the animal health company have depreciated by 13.26% over the course of the past month, underperforming the Medical sector's loss of 6.67% and the S&P 500's loss of 3.97%.Market participants will be closely following the financial results of Zoetis in its upcomi ...

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zoetis Inc. ("Zoetis" or the "Company") (NYSE:ZTS). The investigation concerns whether Zoetis and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [Click here to learn more about the investigation] On April 12, 2024, Investor's Business Daily published a report on Zoetis which alleged that Zoetis "stock crumbled Fr ...

Justin Paget/DigitalVision via Getty Images Introduction Last year, I started covering Zoetis Inc. (NYSE:ZTS), the animal health-focused healthcare giant. My most recent article on this stock was written on January 10, when I went with the title "Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns." Here's a part of my takeaway back then: Despite economic uncertainties, the company anticipates continued success in key franchises, projecting double-digit operational growth for the companion anima ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

Zoetis (ZTS) closed the most recent trading day at $165.69, moving -0.1% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.04%. Meanwhile, the Dow experienced a drop of 0.03%, and the technology-dominated Nasdaq saw an increase of 0.03%.Prior to today's trading, shares of the animal health company had lost 8.95% over the past month. This has lagged the Medical sector's loss of 0.6% and the S&P 500's gain of 2.57% in that time.Market participants will be closel ...

FatCamera In my last article, I mentioned my desire to reduce (and potentially, eliminate) my exposure to bio-pharma companies. So, the fact that I’m writing a bullish piece on Zoetis Inc. (NYSE:ZTS) here might come as a surprise. But, in today’s report I’m going to discuss why I view Zoetis in a more positive light than other, better known, healthcare stocks such as Amgen (AMGN), Johnson and Johnson (JNJ), and Pfizer (PFE). Simply put, since spinning off from Pfizer, Zoetis has produced very unique com ...

FatCamera Introduction As you guys probably know, I like dividend growth investing. With dividend growth investing, you can compound your wealth in a sustainable way and if you invest in dividend growth stocks, the chances are high that you have exposure to high-quality and resilient companies. The composition of a dividend growth portfolio depends heavily on your time horizon, but if you have a lot of time on your side, it is a good idea to also buy some companies with high dividend growth rates. This brou ...

Particular financial metrics have been proven to indicate market-beating potential when analyzing stocks. Three examples are businesses with consistently growing dividend payments and a low payout ratio, steady share repurchases, and a high and rising return on invested capital. Finding companies that meet these requirements creates a "stocked pond" for us to fish in.One business swimming around in this stocked pond is animal health specialist Zoetis (ZTS 0.06%). It's achieved a total return above 500% sinc ...